Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort
Allergy2021Vol. 76(6), pp. 1765–1775
Citations Over TimeTop 1% of 2021 papers
Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Ćustović, A. Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Xepapadaki, Rola Abou‐Taam, Ioana Agache, José A. Castro‐Rodríguez, Zhimin Chen, Pierrick Cros, J.‐C. Dubus, Zeinab El-Sayed, Rasha El‐Owaidy, Wojciech Feleszko, Vincenzo Fierro, Alessandro Fiocchi, Luis García‐Marcos, Anne Goh, Elham Hossny, Yunuen R. Huerta Villalobos, Tuomas Jartti, P. Le Roux, Julia Levina, Aida Inés López García, Ángel Mazón, Mário Morais‐Almeida, Clare Murray, Karthik Nagaraju, Major Nagaraju, Elsy M. Navarrete-Rodríguez, Leyla S. Namazova-Baranova, Antonio Nieto, César Fireth Pozo Beltrán, Thanaporn Ratchataswan, Daniela Rivero‐Yeverino, Eréndira Rodríguez Zagal, Cyril Schweitzer, Marleena Tulkki, Katarzyna Wasilczuk, Dan Xu, PeARL collaborators, on behalf of the PeARL Think Tank
Abstract
Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.
Related Papers
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management(2022)21 cited
- → Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”(2021)4 cited
- → Fachinformationen zu SARS-CoV-2/COVID-19(2020)